Skip to search.
 TSX Down 0.53% TSX Ventures Down 0.63%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
4.69 Down 0.09(1.88%) 4:00PM EDT
|After Hours : 4.69 Down 0.00 (0.02%) 4:17PM EDT
Prev Close:4.78
Open:4.75
Bid:4.65 x 100
Ask:5.98 x 700
1y Target Est:8.00
Beta:0.459809
Next Earnings Date:N/A
Day's Range:4.63 - 4.78
52wk Range:3.55 - 18.60
Volume:47,016
Avg Vol (3m):62,655
Market Cap:161.58M
P/E (ttm):111.67
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIRDown 1.88%161.58M
UCBJYDown 1.10%14.95B
BIIBDown 0.88%67.89B
ABTDown 1.21%61.27B

Key Statistics

Forward P/E (1 yr):67.00
P/S (ttm):1.90
Ex-Dividend Date:14-Oct-15

Analysts

Annual EPS Est (Dec-15) :0.08
Quarterly EPS Est (Dec-15) :0.06
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback